SCHEMBL7380731

SCHEMBL7380731

N#CCC(=O)c1cccc(Cl)c1Cl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ERCC5 P28715 2/20 0.56
FEN1 P39748 2/20 0.56
TSHR P16473 1/20 0.53
MAPT P10636 2/20 0.50
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
TAS1R3 Q7RTX0 1/20 0.44
TAS1R1 Q7RTX1 1/20 0.44
TAS1R2 Q8TE23 1/20 0.44
HTT P42858 1/20 0.43
MGAM O43451 1/20 0.43
AMY1A P0DUB6 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
P2RX7 Q99572 5/20 0.42
JAK2 O60674 1/20 0.41
ALDH1A1 P00352 2/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL135637 0.85 MAPT (0.56) ERCC5FEN1MAPTMEN1KMT2A
SCHEMBL30440405 0.83 MAPT (0.48) ERCC5FEN1TSHRMAPTMEN1
SCHEMBL9080934 0.83 MAPT (0.48) ERCC5FEN1TSHRMAPTMEN1
SCHEMBL2089796 0.83 MAPT (0.49) ERCC5FEN1TSHRMAPTMEN1
SCHEMBL16253911 0.83 MAPT (0.48) ERCC5FEN1TSHRMAPTMEN1
SCHEMBL2071218 0.79 FEN1 (0.52) FEN1MAPTMEN1KMT2ATAS1R3
SCHEMBL395494 0.78 MAPT (0.56) MAPTMEN1KMT2AHTTGAA
SCHEMBL3767429 0.78 ALDH1A1 (0.59) ERCC5FEN1TSHRMAPTMEN1
SCHEMBL3142115 0.77 ERCC5 (0.62) ERCC5FEN1TSHRMEN1KMT2A
SCHEMBL24410395 0.76 MAPT (0.41) ERCC5FEN1TSHRMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488519-B1 PYRAZOLOPYRIDINE DERIVATIVES AS ANTICANCER AGENT PF MEDICAMENT (FR) 2015-06-10 EP disclosed
US-8889711-B2 Pyrazolopyridine derivatives as anticancer agent PIERRE FABRE MEDICAMENT (FR) 2014-11-18 US disclosed
EP-0459830-A1 Pharmacologically active CNS compounds THE WELLCOME FOUNDATION LIMITED (GB) 1991-12-04 EP disclosed
EP-0044119-B1 PROCESS FOR THE PREPARATION OF COPOLYMERS OF ETHYLENE WITH AT LEAST ONE OTHER 1-ALKENE STAMICARBON B.V. (NL) 1985-05-29 EP disclosed
US-4435552-A COORDINATION CATALYST CONTAINING HALOACYL COMPOUND STAMICARBON B.V. (NL) 1984-03-06 US disclosed
EP-0044119-A2 Process for the preparation of copolymers of ethylene with at least one other 1-alkene STAMICARBON B.V. (NL) 1982-01-20 EP disclosed